| 產(chǎn)品名稱(chēng) |
Vaccinia virus |
| 商品貨號 |
B163141 |
| Classification |
Poxviridae, Orthopoxvirus |
| Deposited As |
Vaccinia virus, Orthopoxvirus |
| Agent |
Vaccinia virus |
| Strain |
Lederle-Chorioallantoic |
| Applications |
The seed strain was used at Lederle Laboratories for preparation of smallpox calf lymph vaccine. |
| Biosafety Level |
2 CDC BMBL recommends vaccinationref
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
clinical specimen - human |
| Product Format |
frozen |
| Storage Conditions |
-70° or colder
(or colder) |
| Comments |
The virus is very resistant and may contaminate the laboratory. The seed strain was used at Lederle Laboratories for preparation of smallpox calf lymph vaccine. |
| Effect on Host |
Cytopathic effects in tissue culture Death of embryo Pocks on chorioallantoic membrane |
| Recommended Host |
chicken embryo, chorioallantoic membrane inoculation chicken embryo; chicken embryo; rabbit kidney cells; hamster kidney cells; KB cells (ATCC CCL-17); WI-38 cells (ATCC CCL-75); LLC-MK2 cells (ATCC CCL-7); Vero cells (ATCC CCL-81) |
| Growth Conditions |
Incubation: 3-4 days |
| Cryopreservation |
Storage temperature: -70°C |
| Name of Depositor |
PJ Vasington |
| Special Collection |
ATCC |
| Source |
clinical specimen - human |
| References |
Vaccination recommended for laboratory staff manipulating vaccinia, monkeypox, or cowpox viruses [CDC/NIH Biosafety in Microbiological and Biomedical Laboratories, 4th ed, 1999 - stock no. 017-040-00547-4].
or colder
man, New York City Department of Health strain
or colder
|
